Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Leadership at UCLPartners

8 July 2020

UCLPartners’ Board are delighted to announce that Professor Mike Roberts has been confirmed in the substantive role of Managing Director of UCLPartners, and the term of our Chair, Rt. Hon. Professor Lord Kakkar, has been extended to end March 2021.

Mike has been Interim Managing Director of UCLPartners since December 2019, alongside his roles as Professor of Medical Education for Clinical Practice at Queen Mary University of London, Implementation Lead at NIHR North Thames Applied Research Collaboration (ARC) and Associate Director of the Clinical Quality Improvement Department of the Royal College of Physicians. He has held a number of director roles at UCLPartners since 2011.

Lord Kakkar has been Chair of UCLPartners since 2014. He is also Chair of The King’s Fund, Professor of Surgery at UCL and Director of the Thrombosis Research Institute.

Rt. Hon. Professor Lord Kakkar, PC, said: “The Board is delighted to appoint Professor Mike Roberts into the substantive role of Managing Director of UCLPartners. Mike brings extensive clinical leadership experience and strong academic and clinical connections locally, nationally and internationally. His leadership of UCLPartners through the COVID-19 emergency has demonstrated the important role of our academic health science partnership and strong clinical academic leadership in responding rapidly to the unprecedented challenges facing our health and care system.”

Professor Mike Roberts said: “We have a clear commitment across UCLPartners to working together across our region, drawing on the strength of our multiple designations, to translate research and innovation into practice at scale and pace to improve health and wellbeing of our population. I look forward to continuing to work with colleagues to draw on our partnership’s rich clinical academic expertise and extensive networks to drive improvements in patient care and wellbeing.”

Professor Michael Arthur, UCL President & Provost and UCLPartners Board member said: “On behalf of the Board, I would like to thank Lord Kakkar for his dedication and commitment to UCLPartners over many years, and for agreeing to extend his term as Chair while we carry out the search for his successor.”